Disclosures for "Normative Brain Atrophy Modeling Incorporating Intracranial Volume Improves Pre-clinical Detection of Dementia Risk"
-
Mr. Dos Santos Silva has nothing to disclose.
-
Dr. La Rosa has nothing to disclose.
-
Ms. Dereskewicz has nothing to disclose.
-
Ms. Galasso has nothing to disclose.
-
Ms. Graney has nothing to disclose.
-
Mr. Garcia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pareto.
-
Dr. Levy has nothing to disclose.
-
Mr. Sumowski has nothing to disclose.
-
Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care.